Selected research
Industry Research
Pharmaceutical Reverse Logistics Service Industry Research Report 2026
Market perspective
The global Pharmaceutical Reverse Logistics Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Reverse Logistics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Reverse Logistics Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Reverse Logistics Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Reverse Logistics Service include UPS Healthcare, FedEx, ICSConnect (Cencora), Inmar, PharmaLink, Pharma Logistics, SF Express, AWL India and Omni Logistics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Reverse Logistics Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Reverse Logistics Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Reverse Logistics Service Market by Company
UPS Healthcare
FedEx
ICSConnect (Cencora)
Inmar
PharmaLink
Pharma Logistics
SF Express
AWL India
Omni Logistics
Globalink Logistics
Airpharm
Returns Logistics International
Hanzo Logistics
Pharmax Returns
Pharmaceutical Reverse Logistics Service Segment by Type
On-site Service
Off-site Service
Pharmaceutical Reverse Logistics Service Segment by Application
Pharmaceutical
Biopharmaceutical
Pharmaceutical Reverse Logistics Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Reverse Logistics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Reverse Logistics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Reverse Logistics Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Reverse Logistics Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-site Service
- Off-site Service
Applications
- Pharmaceutical
- Biopharmaceutical
Companies covered
- UPS Healthcare
- FedEx
- ICSConnect (Cencora)
- Inmar
- PharmaLink
- Pharma Logistics
- SF Express
- AWL India
- Omni Logistics
- Globalink Logistics
- Airpharm
- Returns Logistics International
- Hanzo Logistics
- Pharmax Returns
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Reverse Logistics Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 On-site Service
- 2.2.3 Off-site Service
- 2.3 Pharmaceutical Reverse Logistics Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical
- 2.3.3 Biopharmaceutical
- 2.4 Assumptions and Limitations
3 Pharmaceutical Reverse Logistics Service Breakdown Data by Type
- 3.1 Global Pharmaceutical Reverse Logistics Service Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Reverse Logistics Service Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Reverse Logistics Service Breakdown Data by Application
- 4.1 Global Pharmaceutical Reverse Logistics Service Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Reverse Logistics Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Reverse Logistics Service Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Reverse Logistics Service Growth Trends by Region
- 5.2.1 Global Pharmaceutical Reverse Logistics Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Reverse Logistics Service Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Reverse Logistics Service Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Reverse Logistics Service Market Dynamics
- 5.3.1 Pharmaceutical Reverse Logistics Service Industry Trends
- 5.3.2 Pharmaceutical Reverse Logistics Service Market Drivers
- 5.3.3 Pharmaceutical Reverse Logistics Service Market Challenges
- 5.3.4 Pharmaceutical Reverse Logistics Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Reverse Logistics Service Players by Revenue
- 6.1.1 Global Top Pharmaceutical Reverse Logistics Service Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Reverse Logistics Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Reverse Logistics Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Reverse Logistics Service Head Office and Area Served
- 6.4 Global Pharmaceutical Reverse Logistics Service Players, Product Type & Application
- 6.5 Global Pharmaceutical Reverse Logistics Service Manufacturers Established Date
- 6.6 Global Pharmaceutical Reverse Logistics Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Reverse Logistics Service Market Size (2021-2032)
- 7.2 North America Pharmaceutical Reverse Logistics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Reverse Logistics Service Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Reverse Logistics Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Reverse Logistics Service Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Reverse Logistics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Reverse Logistics Service Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Reverse Logistics Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Reverse Logistics Service Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Reverse Logistics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Reverse Logistics Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Reverse Logistics Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Reverse Logistics Service Market Size (2021-2032)
- 10.2 South America Pharmaceutical Reverse Logistics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Reverse Logistics Service Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Reverse Logistics Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Reverse Logistics Service Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Reverse Logistics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Reverse Logistics Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Reverse Logistics Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 UPS Healthcare
- 12.1.1 UPS Healthcare Company Information
- 12.1.2 UPS Healthcare Business Overview
- 12.1.3 UPS Healthcare Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.1.4 UPS Healthcare Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.1.5 UPS Healthcare Recent Developments
- 12.2 FedEx
- 12.2.1 FedEx Company Information
- 12.2.2 FedEx Business Overview
- 12.2.3 FedEx Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.2.4 FedEx Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.2.5 FedEx Recent Developments
- 12.3 ICSConnect (Cencora)
- 12.3.1 ICSConnect (Cencora) Company Information
- 12.3.2 ICSConnect (Cencora) Business Overview
- 12.3.3 ICSConnect (Cencora) Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.3.4 ICSConnect (Cencora) Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.3.5 ICSConnect (Cencora) Recent Developments
- 12.4 Inmar
- 12.4.1 Inmar Company Information
- 12.4.2 Inmar Business Overview
- 12.4.3 Inmar Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.4.4 Inmar Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.4.5 Inmar Recent Developments
- 12.5 PharmaLink
- 12.5.1 PharmaLink Company Information
- 12.5.2 PharmaLink Business Overview
- 12.5.3 PharmaLink Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.5.4 PharmaLink Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.5.5 PharmaLink Recent Developments
- 12.6 Pharma Logistics
- 12.6.1 Pharma Logistics Company Information
- 12.6.2 Pharma Logistics Business Overview
- 12.6.3 Pharma Logistics Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.6.4 Pharma Logistics Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.6.5 Pharma Logistics Recent Developments
- 12.7 SF Express
- 12.7.1 SF Express Company Information
- 12.7.2 SF Express Business Overview
- 12.7.3 SF Express Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.7.4 SF Express Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.7.5 SF Express Recent Developments
- 12.8 AWL India
- 12.8.1 AWL India Company Information
- 12.8.2 AWL India Business Overview
- 12.8.3 AWL India Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.8.4 AWL India Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.8.5 AWL India Recent Developments
- 12.9 Omni Logistics
- 12.9.1 Omni Logistics Company Information
- 12.9.2 Omni Logistics Business Overview
- 12.9.3 Omni Logistics Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.9.4 Omni Logistics Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.9.5 Omni Logistics Recent Developments
- 12.10 Globalink Logistics
- 12.10.1 Globalink Logistics Company Information
- 12.10.2 Globalink Logistics Business Overview
- 12.10.3 Globalink Logistics Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.10.4 Globalink Logistics Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.10.5 Globalink Logistics Recent Developments
- 12.11 Airpharm
- 12.11.1 Airpharm Company Information
- 12.11.2 Airpharm Business Overview
- 12.11.3 Airpharm Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.11.4 Airpharm Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.11.5 Airpharm Recent Developments
- 12.12 Returns Logistics International
- 12.12.1 Returns Logistics International Company Information
- 12.12.2 Returns Logistics International Business Overview
- 12.12.3 Returns Logistics International Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.12.4 Returns Logistics International Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.12.5 Returns Logistics International Recent Developments
- 12.13 Hanzo Logistics
- 12.13.1 Hanzo Logistics Company Information
- 12.13.2 Hanzo Logistics Business Overview
- 12.13.3 Hanzo Logistics Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.13.4 Hanzo Logistics Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.13.5 Hanzo Logistics Recent Developments
- 12.14 Pharmax Returns
- 12.14.1 Pharmax Returns Company Information
- 12.14.2 Pharmax Returns Business Overview
- 12.14.3 Pharmax Returns Revenue in Pharmaceutical Reverse Logistics Service Business (2021-2026)
- 12.14.4 Pharmax Returns Pharmaceutical Reverse Logistics Service Product Portfolio
- 12.14.5 Pharmax Returns Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst